Health
A novel tuberculosis regimen shortens treatment course for patients – EurekAlert
A phase III clinical trial led by an investigator at the Medical University of South Carolina found that a novel four-month regimen was just as effective at treating…
IMAGE: Dr. Susan Dorman, pictured here in her laboratory at the Medical University of South Carolina, led the trial of the novel TB treatment.
view more
Credit: Sarah Pack, Medical University of South Carolina.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance…
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now